First-time prescriptions of biological disease-modifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis 2002-2011: data from the NOR-DMARD register

Ann Rheum Dis. 2014 Oct;73(10):1905-6. doi: 10.1136/annrheumdis-2014-205490. Epub 2014 Jul 2.

Authors

Elisabeth Lie¹, Karen M Fagerli¹, Knut Mikkelsen², Erik Rødevand³, Ase Lexberg⁴, Synøve Kalstad⁵, Till Uhlig¹, Tore K Kvien¹

Affiliations

¹ Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
² Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway.
³ Department of Rheumatology, St. Olavs Hospital, Trondheim, Norway.
⁴ Department of Rheumatology, Drammen Hospital, Drammen, Norway.
⁵ Department of Rheumatology, University Hospital of Northern Norway, Tromsø, Norway.

PMID: 24989896
DOI: 10.1136/annrheumdis-2014-205490

No abstract available

Keywords: Ankylosing Spondylitis; DMARDs (biologic); Psoriatic Arthritis; Rheumatoid Arthritis; Spondyloarthritis.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antirheumatic Agents / therapeutic use*
Arthritis / drug therapy*
Arthritis, Psoriatic / drug therapy
Arthritis, Rheumatoid / drug therapy
Biological Products / therapeutic use*
Drug Prescriptions / statistics & numerical data*
Drug Utilization / trends
Humans
Norway
Registries
Spondylarthritis / drug therapy

Substances

Antirheumatic Agents
Biological Products